ExodusPoint Capital Management’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Other funds holding EDIT
DTC
APM
ExodusPoint Capital Management's EDIT Position: Q3 2024 in Review
ExodusPoint Capital Management sold out of Editas Medicine (EDIT) in Q3 2024, closing a stake of 261,381 shares — an estimated $1.22M sold.
ExodusPoint Capital Management first reported a position in EDIT in Q4 2019 and held it in 14 quarters. The position peaked at $3.28M in Q2 2023. 229 funds tracked by Wall St. Rank hold EDIT as of Q3 2024.
- ExodusPoint Capital Management reported no remaining Editas Medicine position as of Q3 2024 after selling out during the quarter.
- ExodusPoint Capital Management sold 261,381 Editas Medicine shares in Q3 2024, an estimated $1.22M.
- ExodusPoint Capital Management first reported a position in Editas Medicine in Q4 2019 and held it in 14 quarters.
- ExodusPoint Capital Management's Editas Medicine position peaked at $3.28M in Q2 2023.
- 229 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2024.
Based on ExodusPoint Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.